Genentech, Idec deal

GNE will provide $9 million upfront in preferred equity and licensing fees, $17.5 million in additional equity funding prior to U.S. approval, and up to $30.5 million

Read the full 279 word article

How to gain access

Continue reading with a
two-week free trial.